Article Text

Download PDFPDF
A negative d-dimer test result alone or combined with low risk clinical status effectively ruled out symptomatic DVT

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 QUESTION: Can a d-dimer assay, alone or combined with clinical examination results, rule out all, proximal, and calf deep venous thrombosis (DVT) in symptomatic patients?

Design

A blinded comparison of d-dimer test results, either alone or combined with a clinical risk assessment score, with duplex ultrasonographic scanning (DUS).

Setting

A university hospital in London, United Kingdom.

Patients

200 consecutive inpatients and outpatients (mean age 58 y, age range 18 to 91 y, 63% women, 59% inpatients) with suspected DVT. Exclusion criteria were previous or chronic DVT, symptom duration >1 month, anticoagulant therapy >48 hours before assessment, or suspected or confirmed pulmonary embolism.

Description of tests and diagnostic standard

Patients were classified as being at low, moderate, or high risk for DVT based on a clinical assessment score that included data on the presence of cancer, immobilisation, localised tenderness or leg swelling, family history, history of leg trauma, unilateral pitting oedema or erythema, dilated superficial veins, hospitalisation within 6 months, and erythema of symptomatic leg only. d-dimer levels were assessed by using a rapid whole blood assay (SimpliRED, Agen Biomedical, Brisbane, Australia) by an examiner who was blinded to the clinical findings. DUS (diagnostic standard) was done in ablinded manner to identify all, proximal, and calf DVT. Patients with inconclusive scan results had repeated scans done until the diagnosis was conclusive.

Main outcome measures

Sensitivity …

View Full Text

Footnotes

  • Source of funding: none stated.

  • For correspondence: Dr AF Lennox, Irvine Vascular Laboratory, 10th Floor, QEQM Wing, St Mary's Hospital, Praed Street, London W2 1NY, UK. Fax +44 (0)20 7725 6416.